Breast Cancer
Controversies in the therapy of early stage breast cancer reviewed
Published in Cancer Weekly, March 14th, 2006
"Breast cancer is the most common malignancy among U.S. women, with more than 200,000 new cases diagnosed annually. In the U.S., mortality from breast cancer has declined in recent years as a result of more widespread screening, leading to earlier detection, as well as advances in the adjuvant treatment of early-stage disease," scientists in the United States reported.
"It is widely accepted that the appropriate use of adjuvant chemotherapy and endocrine therapy improves the disease-free and overall survival of patients with early-stage breast cancer. It is, therefore, standard...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-03-14)
More Articles from Cancer Weekly
- Clinical Trials
Strategy to recruit Asian Americans for cancer clinical trials discussed - Melanoma
Integrin alphavbeta3 and cofilin modulate K1735 melanoma cell invasion - Pancreatic Cancer
p8 proposed as new target of gemcitabine in pancreatic cancer cells - Prostate Cancer
P1NP used to predict metastases, progression, and survival in prostate cancer - Adverse Drug Reaction
Osteonecrosis of the jaw related to pamidronate therapy - Antibiotics
Antibiotic use and survival in advanced cancer patients with infections examined - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
